Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Avadel Pharmaceuticals plc - SIC # 2834 - PHARMACEUTICAL PREPARATIONS
Ticker
Exchange
SIC #
Website
Latest Ticker
AVDL
Nasdaq
2834
www.avadel.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Avadel Pharmaceuticals plc
Form 8.3 -Avadel Pharmaceuticals plc
- Feb 6th, 2026 6:54 am
Form 8.3
- Jan 16th, 2026 8:28 am
BlackRock, Inc. (BLK) to Invest $333.6M in India’s Aditya Birla Renewables Limited
- Jan 16th, 2026 8:26 am
Rechecking Avadel Pharmaceuticals (AVDL) Valuation After Strong Share Price Momentum
- Jan 13th, 2026 7:13 pm
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes
- Jan 12th, 2026 2:05 pm
Do Options Traders Know Something About Avadel Pharmaceuticals Stock We Don't?
- Jan 9th, 2026 6:32 am
Why Analysts See The Alkermes (ALKS) Story Shifting After Avadel Deal And Orexin Data
- Jan 7th, 2026 12:09 am
Assessing Avadel Pharmaceuticals (AVDL) Valuation After Strong 1-Year Share Price Performance
- Dec 20th, 2025 9:07 am
Avadel Pharmaceuticals Announces Completion of Enrollment in Phase 3 REVITALYZ™ Trial in Idiopathic Hypersomnia
- Dec 18th, 2025 5:00 am
Form 8.3 - Amendment
- Dec 15th, 2025 9:34 am
How Recent Deal Developments Are Reshaping The Avadel Pharmaceuticals Investment Story
- Dec 5th, 2025 5:20 pm
Has Avadel’s 115% Rally in 2024 Already Priced In Its Narcolepsy Breakthrough?
- Dec 5th, 2025 4:13 pm
Announcement relating to despatch of Rule 15 proposal
- Dec 5th, 2025 2:01 pm
Announcement relating to despatch of Definitive Proxy Statement and details of Scheme Meeting and Extraordinary General Meeting
- Dec 3rd, 2025 2:47 pm
Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting
- Dec 1st, 2025 2:05 pm
Avadel Pharmaceuticals (AVDL): Evaluating Valuation After Recent Share Price Surge
- Nov 30th, 2025 4:09 am
Avadel (AVDL) Drops 6.7% on Lack of Leads
- Nov 27th, 2025 7:22 am
ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal
- Nov 20th, 2025 7:14 am
3 Prominent Stocks Estimated To Be Up To 35.1% Below Intrinsic Value
- Nov 20th, 2025 4:38 am
Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck
- Nov 19th, 2025 2:20 pm
Scroll